Stilley William B. III

SEC source: 0001213900-23-043129 · ownership.xml · derivative · entry 2

Stilley William B. III · CIK 0001718069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2033-05-23

F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.

F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.

SEC source: 0001213900-23-043129 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,261,779

SEC source: 0001213900-23-018585 · ownership.xml · derivative · entry 1

Stilley William B. III · CIK 0001718069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock, $.0001 par value · 8,000 shares

Expires 2027-12-31

F1 · derivative.exercise_date: The stock options vest over one year in equal quarterly installments.

SEC source: 0001213900-23-000003 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,020,979

F1 · shares: Represents the cancellation of 166,667 previously outstanding shares of restricted common stock of Adial Pharmaceuticals, Inc. originally issued on February 23, 2022.

F1 · balance_after: Represents the cancellation of 166,667 previously outstanding shares of restricted common stock of Adial Pharmaceuticals, Inc. originally issued on February 23, 2022.

SEC source: 0001213900-22-050596 · ownership.xml · derivative · entry 1

Stilley William B. III · CIK 0001718069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-08-21

F1 · derivative.exercise_date: Stock options to purchase 100,000 shares of the Company's common stock, vesting 50% after Purnovate, Inc. has held a pre-IND meeting with the FDA and the balance when the IND is granted.

SEC source: 0001213900-22-009432 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,187,646

F1 · shares: The restricted shares of Adial Pharmaceuticals, Inc. (the "Company") common stock, par value $0.001 per share (the "Common Stock"), vest as to 166,667 shares monthly on a pro rata basis over 24 months commencing March 23, 2022 and vest as to 83,333 shares on the three year anniversary of the grant date.

F1 · balance_after: The restricted shares of Adial Pharmaceuticals, Inc. (the "Company") common stock, par value $0.001 per share (the "Common Stock"), vest as to 166,667 shares monthly on a pro rata basis over 24 months commencing March 23, 2022 and vest as to 83,333 shares on the three year anniversary of the grant date.

SEC source: 0001213900-23-018585 · ownership.xml · derivative · entry 2

Stilley William B. III · CIK 0001718069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock, $.0001 par value · 8,000 shares

Expires 2026-12-31

F1 · derivative.exercise_date: The stock options vest over one year in equal quarterly installments.

SEC source: 0001213900-21-062729 · ownership.xml · nonDerivative · entry 2

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 937,646

F2 · shares: The price reported in Column 4 is a weighted average price. These 10,600 shares of common stock were purchased in multiple transactions at prices ranging from $2.5999 to $2.83, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4

F2 · price: The price reported in Column 4 is a weighted average price. These 10,600 shares of common stock were purchased in multiple transactions at prices ranging from $2.5999 to $2.83, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4

SEC source: 0001213900-21-062729 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 927,046

F1 · shares: The price reported in Column 4 is a weighted average price. These 10,000 shares of common stock were purchased in multiple transactions at prices ranging from $2.54 to $2.60, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4

F1 · price: The price reported in Column 4 is a weighted average price. These 10,000 shares of common stock were purchased in multiple transactions at prices ranging from $2.54 to $2.60, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4

SEC source: 0001213900-21-047517 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

F1 · price: These shares of Common Stock were granted in connection with the Reporting Person's services as director.

SEC source: 0001213900-21-008172 · ownership.xml · derivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2031-02-07

F1 · shares: The option vests pro rata on a monthly basis over 36 months.

F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months.

SEC source: 0001213900-21-005043 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 917,046

F1 · price: The reporting person acquired 201,109 shares of issuer common stock in exchange for an 28.7% interest in Purnovate, LLC ("Purnovate") pursuant to Purnovate's merger into a wholly owned subsidiary of the issuer, as contemplated by that certain Equity Purchase Agreement, dated December 7, 2020, as amended. The shares issued to the reporting person in the merger are currently being held in escrow and are subject to forfeiture during the two-year period following the merger to satisfy claims arising as a result of Purnovate's breach of any of its representations and warranties or covenants in the purchase agreement.

SEC source: 0001213900-23-018585 · ownership.xml · derivative · entry 3

Stilley William B. III · CIK 0001718069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock, $.0001 par value · 8,000 shares

Expires 2025-12-31

F1 · derivative.exercise_date: The stock options vest over one year in equal quarterly installments.

SEC source: 0001213900-20-007568 · ownership.xml · nonDerivative · entry 2

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 715,937

F2 · shares: The price reported in Column 4 is a weighted average price. These 12,652 shares of common stock were purchased in multiple transactions at prices ranging from $1.4350 to $1.50, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These 12,652 shares of common stock were purchased in multiple transactions at prices ranging from $1.4350 to $1.50, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

SEC source: 0001213900-20-007568 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 703,285

F1 · shares: The price reported in Column 4 is a weighted average price. These 12,348 shares of common stock were purchased in multiple transactions at prices ranging from $1.08 to $1.2708, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4

F1 · price: The price reported in Column 4 is a weighted average price. These 12,348 shares of common stock were purchased in multiple transactions at prices ranging from $1.08 to $1.2708, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4

SEC source: 0001213900-20-005545 · ownership.xml · derivative · entry 2

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 460,000

Underlying: Common Stock · 460,000 shares

Expires 2030-03-02

F1 · shares: The option vests pro rata on a monthly basis over 36 months.

F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months.

SEC source: 0001213900-20-005545 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 690,937

SEC source: 0001213900-20-004742 · ownership.xml · derivative · entry 1

Stilley William B. III · CIK 0001718069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock, $.0001 par value · 80,000 shares

Expires 2020-02-25

F1 · security: The stock options vest over one year in equal quarterly installments.

SEC source: 0001213900-19-004001 · ownership.xml · derivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2029-03-09

F1 · shares: These options vest pro rata on a monthly basis over 36 months.

SEC source: 0001213900-18-015548 · ownership.xml · derivative · entry 3

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,800

Underlying: Common Stock · 36,800 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

F1 · price: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

SEC source: 0001213900-18-015548 · ownership.xml · derivative · entry 2

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,800

Underlying: Common Stock · 36,800 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

F1 · price: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

SEC source: 0001213900-18-015548 · ownership.xml · derivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Units · 73,600 shares

Expires 2023-07-31

F1 · shares: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

F1 · price: On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

SEC source: 0001213900-18-010095 · ownership.xml · derivative · entry 9

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,027

Underlying: Common Stock · 80,000 shares

Expires 2023-07-31

F3 · shares: On July 31, 2018, Mr. Stilley purchased 80,000 units (the "Units") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering.

F3 · price: On July 31, 2018, Mr. Stilley purchased 80,000 units (the "Units") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering.

SEC source: 0001213900-18-010095 · ownership.xml · derivative · entry 8

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,800

Underlying: Units · 73,600 shares

Expires 2023-07-31

F4 · price: The warrant to purchase 36,800 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 73,600 shares.

SEC source: 0001213900-18-010095 · ownership.xml · derivative · entry 7

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,027

Underlying: Common Stock · 52,227 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering.

F2 · derivative.exercise_date: The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering.

F2 · derivative.expiration_date: The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering.

SEC source: 0001213900-18-010095 · ownership.xml · derivative · entry 6

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,800

Underlying: Common Stock · 36,800 shares

Expires 2023-07-31

F1 · price: The 36,800 shares of common stock and warrant to purchase 36,800 shares of common stock were received by the reporting person upon consummation of the initial public offering on July 31, 2018 in accordance with a Securities Purchase Agreement dated February 22, 2018.

SEC source: 0001213900-18-010095 · ownership.xml · derivative · entry 5

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,227 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering.

F2 · derivative.exercise_date: The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering.

F2 · derivative.expiration_date: The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering.

SEC source: 0001213900-18-010095 · ownership.xml · nonDerivative · entry 3

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504,000

F3 · shares: On July 31, 2018, Mr. Stilley purchased 80,000 units (the "Units") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering.

F3 · price: On July 31, 2018, Mr. Stilley purchased 80,000 units (the "Units") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering.

SEC source: 0001213900-18-010095 · ownership.xml · nonDerivative · entry 2

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 424,629

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering.

F2 · price: The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering.

SEC source: 0001213900-18-010095 · ownership.xml · nonDerivative · entry 1

Stilley William B. III · CIK 0001718069 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,402

F1 · shares: The 36,800 shares of common stock and warrant to purchase 36,800 shares of common stock were received by the reporting person upon consummation of the initial public offering on July 31, 2018 in accordance with a Securities Purchase Agreement dated February 22, 2018.

F1 · price: The 36,800 shares of common stock and warrant to purchase 36,800 shares of common stock were received by the reporting person upon consummation of the initial public offering on July 31, 2018 in accordance with a Securities Purchase Agreement dated February 22, 2018.